Figure 4.
Radiation dose and survival in non-small cell lung cancer (NSCLC) in patients treated with or without concurrent chemotherapy. High dose group has better overall survival in both Chemo+ and Chemo- groups.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.